Multiple roles of m6A methylation in epithelial-mesenchymal transition

被引:6
|
作者
Zhao, Xueru [1 ,2 ,3 ,4 ]
Li, Xue [1 ,2 ,3 ,4 ]
Li, Xiaohua [1 ,2 ,3 ,4 ]
机构
[1] Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Peoples R China
[2] Henan Eye Hosp, Henan Eye Inst, Henan Key Lab Ophthalmol & Visual Sci, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China
[4] Henan Univ, Peoples Hosp, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Epithelial-mesenchymal transition; Mechanism; RNA modification; m(6)A methylation; CADHERIN GENE-EXPRESSION; PRE-MESSENGER-RNAS; TRANSCRIPTIONAL REPRESSOR; CROSS-LINKING; CARCINOMA; CELLS; MIGRATION; EMT; N-6-METHYLADENOSINE; METHYLTRANSFERASE;
D O I
10.1007/s11033-022-07368-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial-mesenchymal transition (EMT) plays an important role in migration and invasion of cancer cell and the development of tissue fibrosis diseases. N-6-methyladenosine (m(6)A) is the most extensive type of RNA methylation and has aroused extensive interest in recent years. However, m(6)A methylation seems to play different roles in different cancer cells and tissue fibrotic diseases. To determine the function of m(6)A methylation in EMT, we summarized the molecular mechanism of EMT and recent progress in the regulation of EMT by m(6)A methylation, suggesting that m(6)A methylation targets EMT program by affecting the expression of transcription factors, EMT markers, long noncoding RNA and EMT-associated signaling pathways, which provides more possibilities for early diagnosis and treatment.
引用
收藏
页码:8895 / 8906
页数:12
相关论文
共 50 条
  • [21] Arginine methylation in the epithelial-to-mesenchymal transition
    Qin, Jian
    Xu, Jian
    FEBS JOURNAL, 2022, 289 (23) : 7292 - 7303
  • [22] Epithelial-mesenchymal transition
    Kubik, Joanna
    Pawlak, Kamil
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2023, 36 (01) : 18 - 20
  • [23] Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer
    Bure, Irina V.
    Nemtsova, Marina V.
    Zaletaev, Dmitry V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
  • [24] Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition
    Walsh, Logan A.
    Nawshad, Ali
    Medici, Damian
    MATRIX BIOLOGY, 2011, 30 (04) : 243 - 247
  • [25] Inhibition of notch signaling reverses epithelial-mesenchymal transition in esophageal cancer
    Zhou, Xue-Liang
    Xu, Qi-Rong
    Fang, Yi-Hu
    Xu, Hua
    Zou, Bin
    Xue, Chun-Zhu
    Liu, Ji-Chun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 6421 - 6428
  • [26] The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition
    Voon, Dominic Chih-Cheng
    Thiery, Jean Paul
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 471 - 489
  • [27] Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition
    Ma, Yingying
    Zhu, Songbiao
    Yi, Meiqi
    Zhang, Wenhao
    Xue, Yuanyuan
    Liu, Xiaohui
    Deng, Haiteng
    JOURNAL OF PROTEOME RESEARCH, 2022, 21 (05) : 1240 - 1250
  • [28] m6A RNA Methylation in Cardiovascular Diseases
    Wu, Siyi
    Zhang, Shuchen
    Wu, Xiaoguang
    Zhou, Xiang
    MOLECULAR THERAPY, 2020, 28 (10) : 2111 - 2119
  • [29] Mortalin contributes to colorectal cancer by promoting proliferation and epithelial-mesenchymal transition
    Xu, Ming
    Zhang, Yuan
    Cui, Minghua
    Wang, Xinyue
    Lin, Zhenhua
    IUBMB LIFE, 2020, 72 (04) : 771 - 781
  • [30] The miRNAs and Epithelial-Mesenchymal Transition in Cancers
    Lin, Ching-Wen
    Kao, Shih-Han
    Yang, Pan-Chyr
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (33) : 5309 - 5318